Michael Andreini

Michael Andreini's work experience includes being the President & Chief Executive Officer at the Multiple Myeloma Research Foundation (MMRF), where they focus on accelerating a cure for multiple myeloma patients and advancing health equity. Prior to this, they served as the Chief Operating Officer at MMRF.

Before joining MMRF, Michael worked at IQVIA, a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Michael held roles such as Associate Principal, Engagement Leader, Consultant, and Associate Consultant in the Consulting Services division.

Earlier in their career, Michael worked as a Research Analyst at Fuld & Company, providing competitive strategy advice and market insights to clients. Michael also served as a Product Support Technician at Siemens Healthcare, where they contributed to clinical decision-making and treatment pathways through in-vitro and in-vivo diagnostics.

Michael Andreini earned their Bachelor of Arts degree in Chemistry and Economics from Colgate University, where they studied from 2002 to 2006. Michael later pursued further education at Harvard Business School Executive Education, where they enrolled in the program "Accelerating Innovation in Precision Medicine" in 2019. The current end year for this program is unknown.